A detailed history of Dn B Asset Management As transactions in Dexcom Inc stock. As of the latest transaction made, Dn B Asset Management As holds 144,192 shares of DXCM stock, worth $10 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
144,192
Previous 99,440 45.0%
Holding current value
$10 Million
Previous $13.8 Million 18.53%
% of portfolio
0.08%
Previous 0.08%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 05, 2024

BUY
$110.31 - $140.45 $4.94 Million - $6.29 Million
44,752 Added 45.0%
144,192 $16.3 Million
Q1 2024

Apr 12, 2024

SELL
$114.22 - $140.1 $1.17 Million - $1.43 Million
-10,221 Reduced 9.32%
99,440 $13.8 Million
Q4 2023

Jan 04, 2024

SELL
$75.49 - $124.16 $35,253 - $57,982
-467 Reduced 0.42%
109,661 $13.6 Million
Q3 2023

Oct 13, 2023

BUY
$86.06 - $137.93 $3.47 Million - $5.56 Million
40,333 Added 57.79%
110,128 $10.3 Million
Q2 2023

Jul 06, 2023

SELL
$112.47 - $130.98 $33,516 - $39,032
-298 Reduced 0.43%
69,795 $8.97 Million
Q1 2023

Apr 20, 2023

BUY
$104.0 - $122.92 $360,256 - $425,794
3,464 Added 5.2%
70,093 $8.14 Million
Q4 2022

Jan 12, 2023

BUY
$84.98 - $122.67 $225,281 - $325,198
2,651 Added 4.14%
66,629 $7.55 Billion
Q3 2022

Oct 11, 2022

SELL
$76.35 - $94.18 $57,567 - $71,011
-754 Reduced 1.16%
63,978 $5.15 Million
Q2 2022

Jul 08, 2022

BUY
$67.99 - $132.89 $3.34 Million - $6.53 Million
49,171 Added 315.99%
64,732 $4.82 Billion
Q1 2022

Apr 08, 2022

BUY
$94.08 - $130.2 $88,058 - $121,867
936 Added 6.4%
15,561 $1.99 Million
Q4 2021

Jan 12, 2022

BUY
$129.87 - $162.82 $73,116 - $91,667
563 Added 4.0%
14,625 $1.96 Million
Q3 2021

Oct 15, 2021

BUY
$106.71 - $143.18 $42,363 - $56,842
397 Added 2.91%
14,062 $1.92 Million
Q2 2021

Jul 06, 2021

SELL
$80.99 - $107.93 $215,838 - $287,633
-2,665 Reduced 16.32%
13,665 $5.83 Billion
Q1 2021

Apr 15, 2021

BUY
$84.79 - $104.74 $401,565 - $496,048
4,736 Added 40.85%
16,330 $1.47 Million
Q4 2020

Jan 19, 2021

BUY
$78.0 - $104.5 $63,414 - $84,958
813 Added 7.54%
11,594 $1.07 Million
Q3 2020

Oct 14, 2020

BUY
$95.51 - $112.95 $69,626 - $82,340
729 Added 7.25%
10,781 $1.11 Million
Q2 2020

Jul 08, 2020

BUY
$62.68 - $105.34 $630,059 - $1.06 Million
10,052 New
10,052 $4.08 Billion
Q1 2020

Apr 17, 2020

SELL
$47.79 - $75.63 $486,836 - $770,442
-10,187 Closed
0 $0
Q4 2019

Jan 13, 2020

BUY
$36.62 - $57.29 $373,047 - $583,613
10,187 New
10,187 $557,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $26.8B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Dn B Asset Management As Portfolio

Follow Dn B Asset Management As and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dn B Asset Management As, based on Form 13F filings with the SEC.

News

Stay updated on Dn B Asset Management As with notifications on news.